CEO of Providence Therapeutics Brad Sorenson talks about the company’s clinical trials for a made-in-Canada vaccine and how results could bring new hope for Canada’s vaccine shortage problem.
Global News Morning Toronto
How a made-in-Canada vaccine could bring hope for vaccine shortages
More Videos
You are viewing an Accelerated Mobile Webpage.
View Original Article